It’s a devastating statistic: More than 90% of people with type 1 diabetes (T1D) develop diabetic eye disease within 20 years of diagnosis. But thanks to Jennifer Sun, M.D., M.P.H., of Joslin Diabetes Center in Boston, we’re making headway in the fight to prevent eye disease altogether. She is finding ways to diagnose eye disease earlier and faster, with the ultimate goal to help improve health outcomes for people with T1D, so they can be happier and healthier, until cures are found.
Please join us for an inside look, as we present the final video in our seven-part series, Inside the Lab at Boston. See Dr. Sun gives a first-hand overview of the therapies that have impacted eye disease research, the obstacles that are ongoing and, finally, the optimism that eye complications research could have for the T1D community.
Dr. Sun’s hope is that “the research projects I’m doing today, I’ll be able to look at them and say, what we saw from those projects was the elimination of vision loss in patients with type 1 diabetes.”
We agree completely.
If you haven’t seen the other featured videos in this series already, don’t miss out. See how scientists are collaborating to expedite the process of finding cures and improving lives:
- Boston: A Global Leader of Type 1 Diabetes Research is an overview of the leading scientists and institutions for T1D investigations in Boston and JDRF’s role in shaping and supporting this research.
- Beta Cell Replacement Research in Boston looks at the collaborations and skills that researchers in Boston are using to tackle the complex task of replacing beta cells in people with T1D.
- Beta Cell Regeneration Research in Boston asks: Can we internally regenerate and protect existing beta cells, and therefore find cures for T1D?
- Prevention Research in Boston shows experts that are working to delay T1D, or stop it before it starts.
- Immune Therapy Research in Boston asks: Can we redirect the body’s immune response to find cures for T1D?
- Kidney Complications Research in Boston looks at how we are working to prevent the predictable: kidney disease for 1 in 4 people who have T1D.
Funding eye complications research is one of JDRF’s most critical undertakings, essential in our mission to find cures for T1D. Please consider donating today, and we’ll turn type 1 into type none, with your support.